Indazole-Cl

CAS No. 848142-62-1

Indazole-Cl( —— )

Catalog No. M34085 CAS No. 848142-62-1

Indazole-Cl is a selective ER agonist and a selective estrogen receptor modifier (SERM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 159 In Stock
5MG 255 In Stock
10MG 375 In Stock
25MG 562 In Stock
50MG 770 In Stock
100MG 1051 In Stock
200MG 1423 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Indazole-Cl
  • Note
    Research use only, not for human use.
  • Brief Description
    Indazole-Cl is a selective ER agonist and a selective estrogen receptor modifier (SERM).
  • Description
    Indazole-Cl (Ind-Cl) is an Estrogen receptor (ER)-β-specific agonist with inflammatory effect. Indazole-Cl inhibits cyclooxygenase-2 exression reduction induced by hypoxia. And Indazole-Cl inhibits ROS production. Indazole-Cl also inhibits cell migration and invasion by hypoxia increased by hypoxia. Indazole-Cl is potent inhibitor of hypoxia-induced in ammation in vascular smooth muscle cells (VSMCs).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    Estrogen Receptor/ERR
  • Recptor
    Estrogen/progestogen Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    848142-62-1
  • Formula Weight
    260.68
  • Molecular Formula
    C13H9ClN2O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ClC=1N(N=C2C1C=C(O)C=C2)C3=CC=C(O)C=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Park C, et al. Indazole-Cl inhibits hypoxia-induced cyclooxygenase-2 expression in vascular smooth muscle cells. J Mol Endocrinol. 2019 Jul 1;63(1):27-38. ?
molnova catalog
related products
  • Tamoxifen citrate

    Tamoxifen(ICI-46474) is an antagonist of the estrogen receptor in breast tissue via its active metabolite, hydroxytamoxifen.

  • H3B-5942

    H3B-5942 is an orally available, selective estrogen receptor covalent antagonist (SERCA), demonstrates potent ERαantagonist activity in vitro and in vivo.

  • PHTPP

    A potent, selective antagonist of estrogen ERβ receptor; exhibits 36-fold selective for ERβ, and is fully effective as an ERα antagonist.